Legato Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.14M | Hold |
9,784
| – | – | 0.61% | 27 |
|
|
2025
Q1 | $6.21M | Buy |
9,784
+5,277
| +117% | +$3.35M | 0.84% | 9 |
|
|
2024
Q4 | $3.21M | Buy |
4,507
+411
| +10% | +$293K | 0.42% | 35 |
|
|
2024
Q3 | $4.31M | Sell |
4,096
-298
| -7% | -$313K | 0.53% | 23 |
|
|
2024
Q2 | $4.62M | Sell |
4,394
-1,301
| -23% | -$1.37M | 0.62% | 19 |
|
|
2024
Q1 | $5.48M | Buy |
5,695
+200
| +4% | +$192K | 0.66% | 18 |
|
|
2023
Q4 | $4.83M | Hold |
5,495
| – | – | 0.63% | 25 |
|
|
2023
Q3 | $4.52M | Hold |
5,495
| – | – | 0.66% | 22 |
|
|
2023
Q2 | $3.95M | Hold |
5,495
| – | – | 0.53% | 32 |
|
|
2023
Q1 | $4.52M | Hold |
5,495
| – | – | 0.82% | 10 |
|
|
2022
Q4 | $3.96M | Buy |
+5,495
| New | +$3.96M | 0.76% | 11 |
|
|
2021
Q3 | – | Sell |
-2,793
| Closed | -$1.56M | – | 290 |
|
|
2021
Q2 | $1.56M | Buy |
+2,793
| New | +$1.56M | 0.22% | 108 |
|